| Section | Status | BlueTeq | Name |
| 01.05.03 | Formulary |  |
Adalimumab Humira® |
| 01.05.03 | Formulary | |
Adalimumab Amgevita® |
| 10.01.03 | Formulary | |
Adalimumab Amgevita®) (BIOSIMILAR |
| 10.01.03 | Formulary | |
Adalimumab Humira® |
| 03.04.02 | Formulary | |
Benralizumab Fasenra® |
| 01.05.03 | Formulary | |
Infliximab Inflectra® |
| 01.05.03 | Formulary | |
Infliximab Remicade® |
| 01.05.03 | Formulary | |
Infliximab Remsima® |
| 03.04.02 | Formulary | |
Mepolizumab Nucala® |
| 03.04.02 | Restricted Use | |
Omalizumab Xolair® |
| 03.04.02 | Formulary | |
Reslizumab Cinqaero® |
| 01.05.03 | Formulary | |
Tafacitinib Xeljanz® |
| 10.01.03 | Formulary | |
Tofacitinib Xeljanz |
| 01.05.03 | Restricted Use | |
Vedolizumab Entyvio® |
| 08.01.05 | Restricted Use | |
Venetoclax Venclyxto® |